Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Pawlitzki

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 14, 2020
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Drugs|June 4, 2021
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020Niklas Huntemann, Leoni Rolfes, Marc Pawlitzki, et al.
Ebiomedicine|June 15, 2020
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19Marc Pawlitzki, Uwe K Zettl, Tobias Ruck, et al.
Nutrients|July 28, 2018
Lower Serum Zinc Levels in Patients with Multiple Sclerosis Compared to Healthy ControlsMarc Pawlitzki, Julia Uebelhör, Catherine M Sweeney-Reed, et al.
Plos One|January 9, 2025
LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitroRobin Jansen, Marc Pawlitzki, Michael Gliem, et al.
Frontiers in Neurology|March 6, 2026
Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapyTristan Koelsche, Robin Jansen, Lars Masanneck, et al.
International Journal of Molecular Sciences|April 3, 2021
Structure-Function Relationship of Retinal Ganglion Cells in Multiple SclerosisKhaldoon O Al-Nosairy, Marc Horbrügger, Sven Schippling, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2019
Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?Marc Pawlitzki, Tilman Schneider-Hohendorf, Leoni Rolfes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Loss of corticospinal tract integrity in early MS disease stagesMarc Pawlitzki, Jens Neumann, Jörn Kaufmann, et al.
Deutsches Arzteblatt International|September 28, 2023
A Study of the Geographic Accessibility of Outpatient Memory Clinics in GermanyLars Masanneck, Michaela Butryn, Christopher Nelke, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 14, 2020
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Drugs|June 4, 2021
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020Niklas Huntemann, Leoni Rolfes, Marc Pawlitzki, et al.
Ebiomedicine|June 15, 2020
Merits and culprits of immunotherapies for neurological diseases in times of COVID-19Marc Pawlitzki, Uwe K Zettl, Tobias Ruck, et al.
Nutrients|July 28, 2018
Lower Serum Zinc Levels in Patients with Multiple Sclerosis Compared to Healthy ControlsMarc Pawlitzki, Julia Uebelhör, Catherine M Sweeney-Reed, et al.
Plos One|January 9, 2025
LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitroRobin Jansen, Marc Pawlitzki, Michael Gliem, et al.
Frontiers in Neurology|March 6, 2026
Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapyTristan Koelsche, Robin Jansen, Lars Masanneck, et al.
International Journal of Molecular Sciences|April 3, 2021
Structure-Function Relationship of Retinal Ganglion Cells in Multiple SclerosisKhaldoon O Al-Nosairy, Marc Horbrügger, Sven Schippling, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2019
Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?Marc Pawlitzki, Tilman Schneider-Hohendorf, Leoni Rolfes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 30, 2017
Loss of corticospinal tract integrity in early MS disease stagesMarc Pawlitzki, Jens Neumann, Jörn Kaufmann, et al.
Deutsches Arzteblatt International|September 28, 2023
A Study of the Geographic Accessibility of Outpatient Memory Clinics in GermanyLars Masanneck, Michaela Butryn, Christopher Nelke, et al.
Pageof 14